08:35 SHANDONG XINHUA<00719> - Results Announcement Shandong Xinhua Pharmaceutical Company Limited announced on 24/03/2005: (stock code: 00719 ) Year end date: 31/12/2004 Currency: RMB Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 1,524,409 1,341,788 Profit/(Loss) from Operations : (35,030) 75,925 Finance cost : (15,384) (14,018) Share of Profit/(Loss) of Associates : (1,938) N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (52,485) 51,794 % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.115) 0.113 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (52,485) 51,794 Final Dividend : NIL RMB0.04 per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for Annual General Meeting : To Be Announced Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Basis of preparation The accounts have been prepared in accordance with accounting principles generally accepted in Hong Kong and comply with accounting standards issued by the Hong Kong Institute of Certified Public Accountants ("HKICPA"). They have been prepared under the historical cost convention except that, as disclosed in the accounting policies below, property, plant and equipment are stated at valuation. HKICPA has issued a number of new and revised Hong Kong Financial Reporting Standards and Hong Kong Accounting Standards ("new HKFRSs") which are effective for accounting periods beginning on or after 1st January 2005. The Group has not early adopted these new HKFRSs in the accounts for the year ended 31st December 2004. The Group has already commenced an assessment of the impact of these new HKFRSs but is not yet in a position to state whether these new HKFRSs would have a significant impact on its results of operations and financial position. 2. Turnover and loss from operating activities The turnover and loss from operating activities of approximately RMB1,524,409,000 (2003: RMB1,341,788,000)and RMB35,030,000 (2003: profit of RMB75,925,000), respectively, were all generated from continuing operations. 3. Finance costs 2004 2003 RMB'000 RMB'000 Interest on bank loans 15,384 14,824 Less: government subsidies - (806) ------------ ------------ 15,384 14,018 ============ ============ 4. Dividends 2004 2003 RMB'000 RMB'000 Final, proposed of RMBNil (2003: RMB0.04) per share on 307,312,830 (2003: 307,312,830) A shares and 150,000,000 (2003: 150,000,000) H shares - 18,293 ============ ============ 5. (Loss)/earnings per share The calculation of basic (loss)/earnings per share is based on the Group's loss attributable to shareholders of RMB52,485,000 (2003: profit of RMB51,794,000) and based on the weighted average of 457,312,830 (2003: 457,312,830) shares in issue during the year. There was no dilution effect on the basic (loss)/earnings per share for the year ended 31st December 2004 and 2003 as there were no dilutive shares outstanding during the years ended 31st December 2004 and 2003. For more details, please refer to the press announcement today.